Log in or Sign up for Free to view tailored content for your specialty!
Allergy/Asthma
Serology for mite sensitization screening could save $4B over 5 years
A simulation that used serology to screen children with asthma for mite sensitization saved more than $4 billion over 5 years, according to a poster presented at the American Academy of Allergy, Asthma and Immunology Annual Scientific Meeting.
Flagging new referrals, reserving appointments reduces wait time for peanut allergy testing
Automatically flagging new referrals and reserving clinic and challenge appointments for infants allowed for faster scheduling of peanut allergy evaluations than usual, according to a study presented at the American Academy of Allergy, Asthma and Immunology Annual Scientific Meeting.
Log in or Sign up for Free to view tailored content for your specialty!
What is the value of the pediatric ID specialty?
Infectious Diseases in Children asked Janet R. Gilsdorf, MD, DSc (Hon), FPIDS, a past president of the Pediatric Infectious Diseases Society and the Robert P. Kelch Research Professor Emerita at the University of Michigan Medical Center, how she saw the value of the pediatric ID specialty, why she went into the field and what it means to her.
Pediatric ID compensation ‘just too low’
Pediatric infectious disease specialists are the lowest paid physicians compared with all other medical specialties, according to a recent report.
Takhzyro safely reduces monthly attack rate in adolescents with hereditary angioedema
Takhzyro, a monoclonal antibody, was found to safely reduce monthly attack rates in adolescents with hereditary angioedema, according to research presented at the American Academy of Allergy, Asthma and Immunology annual meeting.
High doses of prenatal vitamin D not associated with children’s asthma risk
Women who took high doses of vitamin D supplementation during pregnancy did not impact their child’s risk for asthma by the age of 6 years, according to data recently published in JAMA.
FDA approval of Dupixent for AD in teens ‘changes the game plan’
Regeneron Pharmaceuticals and Sanofi announced that the FDA has approved Dupixent for patients aged 12 to 17 years with moderate-to-severe atopic dermatitis whose disease is not adequately controlled by topical prescriptions or when those therapies are not advisable.
Allergy & Asthma Network CEO shares top takeaways for PCPs from AAAAI annual meeting
New research on food allergy treatments, stewardship of oral corticosteroids, microbiome’s role in allergy development, and shared decision making were some of the highlights at the recent American Academy of Allergy, Asthma and Immunology annual meeting.
Cesarean delivery linked to milk allergy, GERD in offspring
Children delivered by cesarean were more likely to have milk allergy and GERD, according to findings presented at the American Academy of Allergy, Asthma and Immunology.
Eczema reduces children’s sleep quality
Although children with and without atopic dermatitis receive a comparable amount of sleep, children with the condition are more likely to have a reduced quality of sleep, regardless of the severity of disease.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read